The studies of cell damaging and cell growth factors which induce cardiomyopathy

H Kawaguchi1, M Shoki, H Sano

  • 1Department of Cardiovascular Medicine, Hokkaido University School of Medicine, Sapporo, Japan.

Insights

Phosphatidylinositide-specific phospholipase C (PLC) activity and inositol trisphosphate (IP3) production were elevated in cardiomyopathic hamster hearts. Sarcoplasmic reticulum (SR) calcium handling differed between models, potentially explaining myocyte death in BIO 53.58.

Area of Science:

  • Cardiovascular Research
  • Molecular Cardiology
  • Biochemistry

Background:

  • Phosphatidylinositide-specific phospholipase C (PLC) plays a role in cellular signaling.
  • Altered intracellular calcium handling is implicated in cardiomyopathies.
  • Angiotensinogen is a component of the renin-angiotensin system, found in the heart.

Purpose of the Study:

  • To investigate PLC activity and sarcoplasmic reticulum (SR) function in cardiomyopathic hamster models (BIO 14.6 and BIO 53.58) compared to controls (F1b).
  • To examine the expression and distribution of angiotensinogen in these hamster hearts.
  • To correlate biochemical findings with potential mechanisms of myocyte death.

Main Methods:

  • Measurement of PLC activity and inositol trisphosphate (IP3) production.
  • Assessment of sarcoplasmic reticulum (SR) calcium uptake and IP3-stimulated calcium release.
  • Analysis of angiotensinogen mRNA expression and immunohistochemical localization.

Main Results:

  • PLC activity and IP3 production were significantly higher in both cardiomyopathic hamster hearts (BIO 14.6 and BIO 53.58) compared to controls (F1b).
  • SR calcium uptake increased in BIO 14.6 but decreased in BIO 53.58. IP3-stimulated calcium release from SR increased in BIO 14.6 but decreased in BIO 53.58.
  • Angiotensinogen mRNA expression showed no difference between groups or with age. Immunohistochemistry revealed decreased angiotensinogen immunoreactivity in 20-week-old BIO 53.58 hamsters.

Conclusions:

  • Elevated PI response may lead to high intracellular calcium levels in cardiomyopathic myocytes.
  • Deterioration of SR function in BIO 53.58 hamsters, coupled with prolonged high intracellular calcium, may cause myocyte death.
  • Angiotensinogen expression and distribution are largely unaffected by cardiomyopathy or age in these models, suggesting its role in myocyte death is limited.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...